Related Experiment Video
Updated: Aug 7, 2026

11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Endothelial chimerism in transplantation: Looking for needles in a haystack
Marije Koopmans1, Idske C L Kremer Hovinga, Hans J Baelde
1Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. m.koopmans@lumc.nl
Transplantation
|July 11, 2006
Summary
Recipient cells can replace donor endothelium in transplanted organs, a process called endothelial chimerism. However, the low number of these chimeric cells raises questions about their impact on graft survival and transplant outcomes.
Area of Science:
- Transplantation immunology
- Vascular biology
- Organ transplantation
Background:
- Endothelial chimerism, where recipient progenitor cells replace donor endothelium, is observed in transplanted organs.
- It's hypothesized that this replacement reduces alloreactivity, potentially improving graft survival.
- Recent findings indicate a low proportion of recipient-derived endothelial cells in donor organs.
Purpose of the Study:
- To investigate the clinical significance of low-level endothelial chimerism in organ transplantation.
- To address the uncertainty regarding the impact of recipient-derived endothelial cells on graft survival.
- To discuss challenges in accurately assessing endothelial chimerism and its sources.
Main Methods:
- Review of existing literature on endothelial chimerism in organ transplantation.
- Analysis of hypotheses concerning the effect of chimerism on graft outcomes.
- Discussion of limitations in current techniques for detecting and quantifying chimeric cells.
Main Results:
- The extent of recipient endothelial cell replacement in donor organs is often minimal.
- Distinguishing true post-transplant chimerism from pre-existing cells is challenging.
- Current detection methods may lack the specificity and sensitivity to accurately assess chimerism.
Conclusions:
- The functional impact of low-level endothelial chimerism on organ transplant success remains unclear.
- Further research is needed to refine detection techniques and exclude confounding factors like blood transfusions and pregnancies.
- Accurate assessment of chimerism is crucial for understanding its role in transplant immunology and improving patient outcomes.
Related Concept Videos
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

